<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2989">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04326452</url>
  </required_header>
  <id_info>
    <org_study_id>COVID19PEEP2020</org_study_id>
    <secondary_id>GO2 PEEP Study</secondary_id>
    <nct_id>NCT04326452</nct_id>
  </id_info>
  <brief_title>Treating COVID-19 With a Bidirectional Oxygenation Valve</brief_title>
  <official_title>The Use of a Bidirectional Oxygenation Valve in the Management of Respiratory Failure Due to COVID-19 Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TMC HealthCare</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PEEP Medical, LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>TMC HealthCare</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will utilize a single center internal control study design. The objective of this
      study is to determine the feasibility and safety of a bidirectional oxygenation PEEP
      generating mouthpiece when combined with oxygen by non-rebreather face mask, compared to
      support by oxygen non-rebreather face mask alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We have developed a simple and straightforward silicone rubber-made oral appliance that
      promotes positive expiratory airway pressures with the potential to enhance respiratory
      function while preventing and reversing atelectasis and hypoxia. The purpose of this study is
      to compare the use of our bidirectional oxygenation mouthpiece with conventional oxygen
      support versus conventional oxygen support of any Person Under Investigation for infection by
      the COVID-19 virus.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 27, 2020</start_date>
  <completion_date type="Anticipated">March 27, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 27, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pulse oximetry level</measure>
    <time_frame>Change from Baseline pulse oximetry level at 15 minutes post treatment</time_frame>
    <description>The primary endpoint for this feasibility study is pulse oximetry level after treatment with a Bidirectional Oxygenation Valve</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate</measure>
    <time_frame>Change from Baseline clinical measurements at 15 minutes post treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Change from Baseline clinical measurements at 15 minutes post treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Change from Baseline clinical measurements at 15 minutes post treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systemic carbon dioxide</measure>
    <time_frame>Change from Baseline clinical measurements at 15 minutes post treatment</time_frame>
    <description>Venous and arterial blood gases, if available, will be combined to report systemic carbon dioxide.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Coronavirus Infection</condition>
  <arm_group>
    <arm_group_label>Enrolled Subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The purpose of this study is to compare the use of our bidirectional oxygenation mouthpiece with conventional oxygen support versus conventional oxygen support of any Person Under Investigation for infection by the COVID-19 virus.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bidirectional oxygenation mouthpiece</intervention_name>
    <description>Use of our bidirectional oxygenation mouthpiece with conventional oxygen support.</description>
    <arm_group_label>Enrolled Subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Oxygen saturation &lt;93%

          -  Able to provide informed consent

          -  Not currently requiring intubation

          -  Receiving oxygen by face mask

        Exclusion Criteria:

          -  Unable or unwilling to provide informed consent, cognitive impairment

          -  Rapidly decompensating status requiring urgent or emergent higher level of care
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>TMC HealthCare</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalia Elias Calles, MPH</last_name>
      <phone>520-324-5512</phone>
      <email>research@tmcaz.com</email>
    </contact>
    <investigator>
      <last_name>Matthew Weiner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashvinder Khanna, MD</last_name>
      <phone>650-723-4000</phone>
      <email>aashi@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Levitt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory Saint Joseph's Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonya Mathewson, RN</last_name>
      <phone>678-843-6092</phone>
      <email>sbmathe@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Miller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 25, 2020</study_first_submitted>
  <study_first_submitted_qc>March 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2020</study_first_posted>
  <last_update_submitted>October 5, 2020</last_update_submitted>
  <last_update_submitted_qc>October 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

